The influence of microbiota on ferroptosis in intestinal diseases

被引:12
|
作者
Yao, Ting [1 ]
Li, Lanjuan [1 ,2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Natl Clin Res Ctr Infect Dis, Natl Med Ctr Infect Dis,Sch Med,State Key Lab Diag, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Sch Med, 79 Qingchun Rd, Hangzhou 310003, Peoples R China
关键词
Ferroptosis; microbiota; intestinal diseases; oxygen stress; lipid peroxidation; GUT MICROBIOTA; ESCHERICHIA-COLI; OXIDATIVE STRESS; CELL-DEATH; LIPID-PEROXIDATION; COLORECTAL-CANCER; GENE-EXPRESSION; CARBON-MONOXIDE; IRON CHELATION; FATTY-ACID;
D O I
10.1080/19490976.2023.2263210
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ferroptosis is a distinctive form of iron-dependent necrotic cell death, characterized by excessive lipid peroxidation on cellular membranes and compromised cellular antioxidant defenses. Multiple metabolic pathways, including iron and lipid metabolism, as well as antioxidant systems, contribute to the execution of ferroptosis. The gut microbiota exerts regulatory effects on ferroptosis through its microbial composition, biological functions, and metabolites. Notably, most pathogenic bacteria tend to promote ferroptosis, thereby inducing or exacerbating diseases, while most probiotics have been shown to protect against cell death. Given microbiota colonization in the gut, an intimate association is found between intestinal diseases and microbiota. This review consolidates the essential aspects of ferroptotic processes, emphasizing key molecules and delineating the intricate interplay between gut microbiota and ferroptosis. Moreover, this review underscores the potential utility of gut microbiota modulation in regulating ferroptosis for the treatment of intestinal diseases.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Role of Intestinal Microbiota in Inflammatory Bowel Diseases
    Eun, Chang Soo
    INTESTINAL RESEARCH, 2013, 11 (03) : 161 - 168
  • [22] Regulation of Intestinal Microbiota in Pulmonary Fibrosis Diseases
    Shi Xiao-Dong
    Zhao Han
    Liu Dong-Shan
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (02) : 252 - 264
  • [23] The role of gut microbiota in intestinal and liver diseases
    Hrncir, Tomas
    Hrncirova, Lucia
    Kverka, Miloslav
    Tlaskalova-Hogenova, Helena
    LABORATORY ANIMALS, 2019, 53 (03) : 271 - 280
  • [24] Intestinal microbiota - a possible contributor to cardiovascular diseases?
    Iorga, Roua
    Bratu, Ovidiu Gabriel
    Bacalbasa, Nicolae
    Gaman, Mihnea-Alexandru
    Diaconu, Camelia Cristina
    JOURNAL OF MIND AND MEDICAL SCIENCES, 2020, 7 (02): : 168 - 172
  • [25] Intestinal microbiota and the immune system in metabolic diseases
    Panida Sittipo
    Stefani Lobionda
    Yun Kyung Lee
    Craig L. Maynard
    Journal of Microbiology, 2018, 56 : 154 - 162
  • [26] Bibliometric analysis of intestinal microbiota and lung diseases
    Sun, Weiting
    Zhou, Tong
    Ding, Peng
    Guo, Liuxue
    Zhou, Xiujuan
    Long, Kunlan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [27] Intestinal microbiota and allergic diseases: A systematic review
    Melli, L. C. F. L.
    do Carmo-Rodrigues, M. S.
    Araujo-Filho, H. B.
    Sole, D.
    de Morais, M. B.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2016, 44 (02) : 177 - 188
  • [28] Intestinal Microbiota and Metabolic Diseases: Pharmacological Implications
    Shen, Liang
    Ji, Hong-Fang
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (03) : 169 - 171
  • [29] The link between the intestinal microbiota and cardiovascular diseases
    Gerardi, Viviana
    Del Zompo, Fabio
    D'Aversa, Francesca
    Gasbarrini, Antonio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2016, 17 (01) : 11 - 14
  • [30] Ferroptosis as a therapeutic target for inflammation-related intestinal diseases
    Zhang, Xiaoli
    Ma, Yiming
    Lv, Guoqing
    Wang, Hongying
    FRONTIERS IN PHARMACOLOGY, 2023, 14